ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Executives Cash Out as China CEO Buys Big

By ORTEX News · Edited by , Editor, ORTEX News1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Fresh insider filings this week reveal a split between C-suite sellers and one bold buyer making a nine-figure bet.

The biggest buy of the week came from Zhang Bo, CEO of 1378 China Hongqiao Group. He filed two purchases totalling nearly $140M — buying 41.5 million shares between June 8 and 10. That is a rare, high-conviction move at that scale.

On the selling side, US executives dominated. The CEO of GBTG Global Business Travel Group, Paul Abbott, filed $3.6M in share sales across two transactions reported June 10. The timing stands out — filed just days after each trade.

CROX Crocs CEO Vivian Rees filed three separate sales totalling around $3.9M. All trades occurred June 5 and were filed June 9. That cluster of filings in a single day signals a planned disposal.

CLF Cleveland-Cliffs CFO Celso Goncalves filed a $2.9M sale on June 5. The stock has faced pressure from global steel pricing. A CFO selling near that level draws attention.

One notable buy among US names: Mattias Stenberg, CEO of OCTV Octave Intelligence, filed a $1.85M purchase on June 9. That is a significant personal commitment for a smaller-cap company.

QBTS D-Wave Quantum CFO John Markovich filed a $1.3M sale on June 10, trimming exposure in the quantum computing name after a strong recent run.

This is not financial advice. Insider filings reflect disclosed transactions and may not represent forward-looking intent.

Stocks in this article

How this article was generated

Generated
12 Jun 2026, 16:11
Prompt version
v1.0
Data sources
Institutional positioning

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.